ArticlePloS one2024
Efficient lung cancer detection using computational intelligence and ensemble learning.
Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- FPA-based weighted average ensemble of deep learning models for classification of lung cancer using CT scan images.Scientific reports · 2025Article
- IM- LTS: An Integrated Model for Lung Tumor Segmentation using Neural Networks and IoMT.MethodsX · 2025Article
- Retraction: Efficient lung cancer detection using computational intelligence and ensemble learning.PloS one · 2025Article
Corrections and comments
- Retraction · 2025-05-12Cites Retracted Work · Objections by Author(s) ·
- Retracted
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung cancer emerges as a major factor in cancer-related fatalities in the current generation, and it is predicted to continue having a long-term impact. Detecting symptoms early becomes crucial for effective treatment, underscoring innovative therapy's necessity. Many researchers have conducted extensive work in this area, yet challenges such as high false-positive rates and achieving high accuracy in detection continue to complicate accurate diagnosis. In this research, we aim to develop an ecologically considerate lung cancer therapy prototype model that maximizes resource utilization by leveraging recent advancements in computational intelligence. We also propose an Internet of Medical Things (IoMT)-based, consumer-focused integrated framework to implement the suggested approach, providing patients with appropriate care. Our proposed method employs Logistic Regression, MLP Classifier, Gaussian NB Classifier, and Intelligent Feature Selection using K-Means and Fuzzy Logic to enhance detection procedures in lung cancer dataset. Additionally, ensemble learning is incorporated through a voting classifier. The proposed model's effectiveness is improved through hyperparameter tuning via grid search. The proposed model's performance is demonstrated through comparative analysis with existing NB, J48, and SVM approaches, achieving a 98.50% accuracy rate. The efficiency gains from this approach have the potential to save a significant amount of time and cost. This study underscores the potential of computational intelligence and IoMT in developing effective, resource-efficient lung cancer therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.